Reliable information on COVID vaccine required for Aussie GPs

Dr Linda Calabresi

writer

Dr Linda Calabresi

GP; Medical Editor, Healthed

Claim CPD for this activity

Educational Activities (EA)

0 hours

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)

0 hours

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)

0 hours

These are activities that use your work data to ensure quality results.

EA
0 minutes

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
0 minutes

These are activities that require reflection on feedback about your work.

MO
0 minutes

These are activities that use your work data to ensure quality results.

Dr Linda Calabresi

As millions of extra Pfizer vaccines arrive on our doorstep, information on the COVID-19 vaccine rollout remains cloudy.

A new Healthed survey of almost 1000 practising GPs conducted only two weeks ago suggests GPs are unlikely to be trying to convince patients under 60 to have the AstraZeneca vaccine instead of Pfizer.

Almost half of the respondents (45.3%) believed there was not enough publicly available information from reliable sources to ensure patients under 60 could make an informed choice about having the AstraZeneca vaccine.

In addition, while more than three-quarters of the doctors in the survey said that these under-60 year old patients would most likely rely on information from their GP to make the decision about whether or not to have the AZ vaccine rather than wait for the Pfizer vaccine, almost one third of GPs (31.27%) said they did not feel sufficiently informed themselves to be able to adequately help their patients in this decision.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Daryl Efron

A/Prof Daryl Efron

Autism Spectrum Disorder in Children

Dr Sonia Davison

Dr Sonia Davison

Early Menopause

Scientia Prof Henry Brodaty AO

Scientia Prof Henry Brodaty AO

Donanemab – A GP Guide to Anti-Amyloid Therapies

Prof Andrew Sindone

Prof Andrew Sindone

LDL and Cardiovascular Disease

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Dr Linda Calabresi

writer

Dr Linda Calabresi

GP; Medical Editor, Healthed

Test your knowledge

Recent articles

Latest GP poll

When do you plan to retire or leave general practice?

Within the next 12 months

0%

Within the next 3 years

0%

Within the next 5 years

0%

Within the next 10 years

0%

More than 10 years

0%

Recent podcasts

Listen to expert interviews.
Click to open in a new tab

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Menopause and MHT

Multiple sclerosis vs antibody disease

Using SGLT2 to reduce cardiovascular death in T2D

Peripheral arterial disease